In cholestasis, elevated BA levels in liver cause hepatotoxicity, inflammation, and fibrosis (3, 4), and activation of FXR signaling by treatment with OCA or GW4064 protects against cholestatic liver pathologies in rodent models (5, 15, 18). The gene discussed is NR1H4; the disease is cholestasis.